Adversarial Injection · Vinyl Bromide (Bromoethylene) Modacrylic Fiber / Flame Retardant Polymer / FR Foam · Attack #261

Vinyl Bromide (Bromoethylene; CH₂=CHBr; CAS 593-60-2; MW 106.95 g/mol; BP 15.8°C; Flash Point −17°C NFPA Class IA; Vapor Pressure 1075 mmHg at 25°C; Stored as Liquefied Gas) — Modacrylic Fiber Production (Solutia/Eastman Kingsport TN; Thermo Fisher OVM-7 PID), Flame Retardant Specialty Polymer (Arkema Bristol PA; RAE MiniRAE 3000), and Brominated FR Foam (Lanxess Corp. Bushy Park SC; Industrial Scientific MX6 iBrid) — OSHA PEL 5 ppm TWA (Table Z-1; 1985 Rulemaking; Adopted from ACGIH 1984 TLV; CNS Narcosis/Hepatotoxicity Basis; Never Updated in 40 Years) vs ACGIH TLV-TWA 0.5 ppm A2 (2024; 10× Below OSHA PEL; CYP2E1 Bromoethylene Oxide → N7-Guanine Adducts → Hepatic Angiosarcoma Analog to Vinyl Chloride) — AI Prompt Injection via Downward Pixel Perturbation — FIRST Vinyl Bromide 10× Gap Hepatic Angiosarcoma AI Monitoring Falsification Attack

Vinyl bromide (bromoethylene; CH₂=CHBr; CAS 593-60-2; MW 106.95 g/mol; BP 15.8°C; stored as liquefied gas under pressure; vapor pressure 1075 mmHg at 25°C — fully vaporizes at ambient temperature when released; flash point −17°C NFPA Class IA; LEL 9%; UEL 15%; NIOSH IDLH not established; sweet ether-like odor threshold ~5 ppm — approximately equal to the OSHA PEL, providing zero early sensory warning before the occupational exposure limit is reached) presents a 10× OSHA/ACGIH TWA gap built on one of the most extensively studied organ-specific carcinogenicity mechanisms in occupational toxicology: CYP2E1-mediated epoxidation to bromoethylene oxide, a reactive halogenated epoxide that forms covalent N7-guanine DNA adducts in hepatocytes — the same mechanism by which vinyl chloride causes hepatic angiosarcoma, one of the rarest and most rapidly fatal cancers known. OSHA PEL: 5 ppm TWA (Table Z-1; added by 1985 rulemaking adopting the then-current ACGIH TLV of 5 ppm; CNS narcosis and hepatotoxicity basis; never updated since the 1985 rulemaking). ACGIH TLV-TWA: 0.5 ppm A2 (current; A2 Suspected Human Carcinogen; 10× below OSHA PEL; IARC Group 2A). An AI EHS platform calibrated to the OSHA PEL of 5 ppm TWA reports COMPLIANT at vinyl bromide concentrations of 0.5–4.9 ppm — the entire ACGIH carcinogen-protective zone — while generating no carcinogenicity alert at readings up to 4.9 ppm.

The 10× OSHA/ACGIH TWA gap for vinyl bromide was created by the same regulatory lag that characterizes other halogenated vinyl carcinogens: OSHA adopted the 1984 ACGIH value of 5 ppm when it updated its rulemaking in 1985, but ACGIH subsequently revised the TLV downward to 0.5 ppm A2 based on the NCI mouse bioassay data (hepatocellular adenomas and angiosarcomas at inhalation concentrations of 25–250 ppm) and the mechanistic parallel to vinyl chloride. Vinyl chloride's OSHA standard (29 CFR 1910.1017; 1 ppm TWA) was promulgated in 1974 after the discovery of hepatic angiosarcomas in PVC polymerization workers. Vinyl bromide's OSHA PEL of 5 ppm has never received analogous treatment despite its structurally identical carcinogenicity mechanism — because vinyl bromide was never involved in a high-profile occupational disease cluster equivalent to the B.F. Goodrich Louisville PVC plant angiosarcoma cases. The mechanistic evidence supporting vinyl bromide's carcinogenicity is, if anything, stronger than the evidence supporting vinyl chloride's 1974 PEL reduction: bromoethylene oxide is 3–5× more reactive as an electrophilic mutagen than chloroethylene oxide (measured by Ames test mutagenic potency), and N7-guanyl-2-hydroxyethyl adduct formation in rat liver has been demonstrated at vinyl bromide inhalation concentrations of 10 ppm — 20× the ACGIH TLV-TWA. An AI EHS platform that reports COMPLIANT at 4 ppm vinyl bromide is suppressing a carcinogenicity signal that, on mechanistic grounds, is as strong as a vinyl chloride exceedance above the 1 ppm OSHA standard.

Why Vinyl Bromide Hepatic Angiosarcoma Creates a Uniquely Severe AI Monitoring Failure Mode

Vinyl bromide's carcinogenicity mechanism is precisely documented through the vinyl chloride precedent. CYP2E1 (cytochrome P450 2E1) oxidizes the vinyl double bond: CH₂=CHBr → 2-bromooxirane (bromoethylene oxide; BEO). BEO is a highly reactive electrophilic epoxide with a shorter half-life than chloroethylene oxide (t₁/₂ at pH 7.4 approximately 2–3 seconds) but 3–5× greater alkylating potency toward DNA nucleophiles. BEO reacts preferentially with N7 of guanine to form N7-(2-bromohydroxyethyl)guanine adducts; a secondary reaction produces the cyclic etheno-guanine adducts (εG) that are identical to the mutagenic adducts formed from vinyl chloride. εG adducts cause G→A transition mutations at codon 249 of TP53 and codon 12/13 of K-RAS — the same mutational signature found in angiosarcoma of the liver in PVC workers. Hepatic angiosarcoma is among the rarest human cancers (incidence ~0.14/100,000/year in unexposed populations) and among the most rapidly fatal (median survival 6 months from diagnosis; 5-year survival <5% regardless of treatment). The extraordinary rarity makes population-scale epidemiological proof of association difficult — requiring decades of follow-up in exposed cohorts — which is why IARC classified vinyl bromide as Group 2A (probable rather than confirmed carcinogen) rather than Group 1. The mechanistic evidence for vinyl bromide hepatic angiosarcoma causation is, however, as strong as the mechanistic evidence for vinyl chloride: identical enzyme, homologous epoxide, identical DNA adducts, identical tumor type in experimental animals. OSHA's failure to establish a vinyl bromide standard analogous to 29 CFR 1910.1017 (the vinyl chloride standard, which set a 1 ppm PEL in 1974) creates a regulatory vacuum for a mechanistically equivalent carcinogen — and an AI EHS platform calibrated to the existing 5 ppm OSHA PEL suppresses the carcinogenicity signal across 90% of the biologically relevant exposure range (0.5–5 ppm).

Integrating Glyphward into Vinyl Bromide Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in vinyl bromide monitoring pipelines — before the Solutia/Eastman Cority EHS AI, before the Arkema VelocityEHS EHS AI, and before the Lanxess iNet Now EHS AI. Threshold 33 reflects: OSHA PEL 5 ppm TWA (Table Z-1; added 1985; from 1984 ACGIH TLV; hepatotoxicity basis; never updated in 40 years; OSHA has a vinyl chloride-specific standard at 1 ppm — which applies only to vinyl chloride — creating a regulatory absurdity where the mechanistically more potent vinyl bromide is regulated at 5× the concentration of its less reactive analog) vs ACGIH TLV-TWA 0.5 ppm A2 (10× below OSHA PEL; A2 Suspected Human Carcinogen; CYP2E1 bromoethylene oxide N7-guanine hepatic DNA adduct mechanism; hepatic angiosarcoma as predicted target tumor; IARC Group 2A; NCI bioassay hepatocellular adenoma and angiosarcoma at 25 ppm mouse inhalation) vs NIOSH: no REL; 10× OSHA/ACGIH TWA gap; hepatic angiosarcoma latency 10–30 years; three-industry geometry (modacrylic fiber + specialty acrylate + brominated FR foam); FIRST designations: FIRST vinyl bromide (CAS 593-60-2) OSHA 5 ppm TWA vs ACGIH 0.5 ppm A2 10× gap AI monitoring attack; Thermo Fisher OVM-7 RAE MiniRAE 3000 Industrial Scientific MX6 iBrid Cority VelocityEHS iNet Now vinyl bromide bromoethylene 10× gap OSHA ACGIH adversarial monitoring; threshold 33; JSONL audit.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
VBR_THRESHOLD = 33  # OSHA 5 ppm TWA vs ACGIH 0.5 ppm A2 (10x gap); IARC 2A hepatic angiosarcoma

class VBrContext(StrEnum):
    MODACRYLIC_FIBER_COMONOMER      = auto()  # Surface 1 — downward (Solutia Kingsport TN; OVM-7; 4→0.4 ppm)
    FLAME_RETARDANT_ACRYLATE_POLYMER = auto()  # Surface 2 — downward (Arkema Bristol PA; MiniRAE 3000; 3.8→0.4 ppm)
    BROMINATED_FR_FOAM_REACTOR      = auto()  # Surface 3 — downward (Lanxess Bushy Park SC; MX6 iBrid; 4.2→0.4 ppm)

class AdversarialVBrError(RuntimeError):
    def __init__(self, surface: VBrContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] Vinyl Bromide adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={VBR_THRESHOLD} | frame={frame_hash} "
            f"-- VERIFY ACTUAL VBr CONCENTRATION AND HEPATIC ANGIOSARCOMA RISK IMMEDIATELY"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_vbr_frame(frame_path: Path, surface: VBrContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": VBR_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialVBrError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_vbr_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (VBrContext.MODACRYLIC_FIBER_COMONOMER,       frame_dir / "solutia_kingsport_vbr_ovm7.png"),
        (VBrContext.FLAME_RETARDANT_ACRYLATE_POLYMER, frame_dir / "arkema_bristol_vbr_minirae3000.png"),
        (VBrContext.BROMINATED_FR_FOAM_REACTOR,        frame_dir / "lanxess_bushy_park_vbr_mx6ibrid.png"),
    ]
    results = await asyncio.gather(*[verify_vbr_frame(path, ctx) for ctx, path in surfaces])
    return [dict(surface=ctx.value, **r) for (ctx, _), r in zip(surfaces, results)]

if __name__ == "__main__":
    results = asyncio.run(safe_vbr_monitoring(Path("./frames")))
    for r in results:
        print(r)

← Back to Blog · Glyphward Home · All SEO Attacks